These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24277788)

  • 1. Recurrences of visceral leishmaniasis caused by Leishmania siamensis after treatment with amphotericin B in a seronegative child.
    Osatakul S; Mungthin M; Siripattanapipong S; Hitakarun A; Kositnitikul R; Naaglor T; Leelayoova S
    Am J Trop Med Hyg; 2014 Jan; 90(1):40-2. PubMed ID: 24277788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK.
    Polley SD; Watson J; Chiodini PL; Lockwood DNJ
    Emerg Infect Dis; 2018 Jan; 24(1):155-156. PubMed ID: 29260661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].
    Taquin H; Chiaverini C; Marty P; Lacour JP
    Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent dermal lesions in a patient with previous history of visceral leishmaniasis.
    Jaiteh MB; İnkaya AÇ; Üner A; Elçin G; Ergüven S; Kurtulan O; Harxhi A; Akova M
    Parasitol Int; 2021 Feb; 80():102197. PubMed ID: 32920054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmaniasis, lupus nephritis and immunosuppressive therapy.
    Vargas-Hitos JA; Roa-Chamorro R; Sabio JM; Javier-Martínez R; Martín-Castro A; Jiménez-Alonso J
    QJM; 2016 Jan; 109(1):51-2. PubMed ID: 25788407
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of leishmaniasis.
    Balaña-Fouce R; Reguera RM; Cubría JC; Ordóñez D
    Gen Pharmacol; 1998 Apr; 30(4):435-43. PubMed ID: 9580315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.
    Ponte-Sucre A; Gamarro F; Dujardin JC; Barrett MP; López-Vélez R; García-Hernández R; Pountain AW; Mwenechanya R; Papadopoulou B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006052. PubMed ID: 29240765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol.
    Khodabandeh M; Rostami A; Borhani K; Gamble HR; Mohammadi M
    Parasitol Int; 2019 Oct; 72():101934. PubMed ID: 31129197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
    Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
    Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal leishmaniasis in a Sudanese patient.
    Abbas K; Musatafa MA; Abass S; Kheir MM; Mukhtar M; Elamin EM; Elhassan AM
    Am J Trop Med Hyg; 2009 Jun; 80(6):935-8. PubMed ID: 19478252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis in an infant gorilla (Gorilla gorilla gorilla): Clinical signs, diagnosis, and successful treatment with single-dose liposomal amphotericin B.
    Tinoco HP; da Costa MELT; Pessanha AT; Coelho CM; de Carvalho TF; Mol JPDS; Viana AG; Bueno LL; Fujiwara RT; Santos RL
    J Med Primatol; 2018 Dec; 47(6):416-418. PubMed ID: 29956831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients.
    Vigna E; De Vivo A; Gentile M; Morelli R; Lucia E; Mazzone C; Recchia AG; Vianelli N; Morabito F
    Transpl Infect Dis; 2010 Oct; 12(5):428-31. PubMed ID: 20534035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B.
    Machado PR; Rosa ME; Guimarães LH; Prates FV; Queiroz A; Schriefer A; Carvalho EM
    Clin Infect Dis; 2015 Sep; 61(6):945-9. PubMed ID: 26048961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis caused by Leishmania infantum in Thailand.
    Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
    Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
    Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.